Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma

Overview of attention for article published in Frontiers in Molecular Biosciences, December 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,487 followers.

New Research: Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma https://t.co/UoheEYxEg2 #MolBioSci

03 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.